Show simple item record

dc.contributor.author Kim, Suhyun
dc.date.accessioned 2018-10-02T20:00:00Z
dc.date.available 2018-10-02T20:00:00Z
dc.date.issued 2018-08-23
dc.date.submitted 2018-10-02T20:00:00Z en
dc.identifier.citation AMA en_US
dc.identifier.uri http://hdl.handle.net/1993/33504
dc.description.abstract Glioblastoma multiforme (GB) is the most common and most aggressive brain cancer in adults with a median survival time after diagnosis of 12 months even with multimodal treatments. Chemotherapeutics have limited response in GB due to inadequate drug accumulation at the tumor site. In response to limited chemotherapeutic options for treating GB, many researchers are investigating the use of nanoparticles (NPs), synthetically engineered particulates that are < 100 nm in size, as a novel drug delivery mechanism. The present study examined two different non-spherical magnetic nanoparticles in an effort to understand the mechanisms governing nanoparticle accumulation, cellular drug delivery and cytotoxicity in established human GB cell lines. The hypothesis of these studies is that nanoparticle accumulation occurs through specific endocytic pathways that can be altered by application of external magnetic fields. Two non-spherical shaped iron oxide nanoparticles (IONPs), iron oxide nanodiscs (IONDs) and iron oxide nanobricks (IONBs) with identical surface coating of N-(trimethoxysilylpropyl) ethylenediaminetriacetate trisodium salt (EDT) were evaluated for cellular accumulation, drug delivery and cytotoxic response profiles using established human GB cell lines. Both IONP compositions showed both temperature-dependent and magnetic field-dependent cellular accumulation. Cell accumulation appeared to be through a caveolin-based endocytic pathway. Doxorubicin (DOX) loading onto the IONP was greatest for EDT-IONB composition and these nanoparticles were further shown to produce cytoxic responses in GB cells. Based on these studies, EDT-IONB is a reasonable nanoparticle composition to advance for further in vivo studies for glioblastoma treatment. en_US
dc.description.sponsorship Natural Science and Engineering Research Council of Canada and Canadian Institutes of Health Research. en_US
dc.subject Glioblastoma multiforme (GB) en_US
dc.subject EDT-IONB en_US
dc.subject nanoparticles (NPs) en_US
dc.subject iron oxide nanoparticles (IONPs) en_US
dc.title Development and Characterization of Magnetic Nanoparticles for Treating Glioblastoma en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

View Statistics